Chemoinformaics analysis of Taxifolin 3-O-beta-D-xylopyranoside
| Molecular Weight | 436.369 | nRot | 3 |
| Heavy Atom Molecular Weight | 416.209 | nRig | 0 |
| Exact Molecular Weight | 436.101 | nRing | 4 |
| Solubility: LogS | -2.672 | nHRing | 2 |
| Solubility: LogP | 3.702 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 55.5579 |
| nHD | 7 | BPOL | 26.1401 |
| QED | 0.564 |
| Synth | 2.2 |
| Natural Product Likeliness | 1.158 |
| NR-PPAR-gamma | 0.079 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.207 |
| HIA | 0.004 |
| CACO-2 | -4.323 |
| MDCK | 0.0000212 |
| BBB | 0.919 |
| PPB | 0.902135 |
| VDSS | 1.11 |
| FU | 0.115758 |
| CYP1A2-inh | 0.879 |
| CYP1A2-sub | 0.699 |
| CYP2c19-inh | 0.406 |
| CYP2c19-sub | 0.436 |
| CYP2c9-inh | 0.272 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.206 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.118 |
| CL | 8.709 |
| T12 | 0.465 |
| hERG | 0.049 |
| Ames | 0.01 |
| ROA | 0.028 |
| SkinSen | 0.576 |
| Carcinogencity | 0.064 |
| EI | 0.984 |
| Respiratory | 0.183 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.726063 |